First Time Loading...

Gritstone bio Inc
NASDAQ:GRTS

Watchlist Manager
Gritstone bio Inc Logo
Gritstone bio Inc
NASDAQ:GRTS
Watchlist
Price: 0.9627 USD 10.66% Market Closed
Updated: May 5, 2024

Gritstone bio Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gritstone bio Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Gritstone bio Inc
NASDAQ:GRTS
Revenue
$16.3m
CAGR 3-Years
59%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Gritstone bio Inc
Revenue Breakdown

Breakdown by Geography
Gritstone bio Inc

Not Available

Breakdown by Segments
Gritstone bio Inc

Total Revenue: 16.3m USD
100%
Grant: 15m USD
91.9%
License: 1.3m USD
8.1%
Collaboration Revenue: 300k USD
1.8%

See Also

What is Gritstone bio Inc's Revenue?
Revenue
16.3m USD

Based on the financial report for Dec 31, 2023, Gritstone bio Inc's Revenue amounts to 16.3m USD.

What is Gritstone bio Inc's Revenue growth rate?
Revenue CAGR 5Y
69%

Over the last year, the Revenue growth was -18%. The average annual Revenue growth rates for Gritstone bio Inc have been 59% over the past three years , 69% over the past five years .